2010
DOI: 10.1016/j.radonc.2010.02.005
|View full text |Cite
|
Sign up to set email alerts
|

Quality of life as predictor of survival: A prospective study on patients treated with combined surgery and radiotherapy for advanced oral and oropharyngeal cancer

Help me understand this report

Search citation statements

Order By: Relevance

Paper Sections

Select...
4

Citation Types

2
37
0
4

Year Published

2010
2010
2023
2023

Publication Types

Select...
8
1

Relationship

0
9

Authors

Journals

citations
Cited by 57 publications
(43 citation statements)
references
References 41 publications
2
37
0
4
Order By: Relevance
“…Other side effects include malnutrition and problems with deglutition, mastication, speech, and taste [6]. These functional challenges have a profound impact on quality of life (QOL) [7], which is an important treatment endpoint given that both disease-specific and overall survival have been shown to be affected by deterioration of QOL in this population [8]. …”
Section: Introductionmentioning
confidence: 99%
“…Other side effects include malnutrition and problems with deglutition, mastication, speech, and taste [6]. These functional challenges have a profound impact on quality of life (QOL) [7], which is an important treatment endpoint given that both disease-specific and overall survival have been shown to be affected by deterioration of QOL in this population [8]. …”
Section: Introductionmentioning
confidence: 99%
“…The use of PORT in oral cavity cancer involves substantial acute toxicity, and even more concerning, a significant risk for late effects [8,9] that might impair the patients' quality of life [10,11] yet is not based upon randomized evidence [4]. Some studies have failed to demonstrate a benefit for PORT in head and neck squamous cell carcinoma (HNSCC) [12,13].…”
Section: Introductionmentioning
confidence: 99%
“…N stage 2-3), positive surgical margins and extra-capsular extension (ECE) [4]. The latter two factors, which place individuals at a very high-risk of loco-regional and distant failure, are indications for post-operative chemo-radiation based upon the results of phase III trials and a subsequent meta-analysis [5][6][7].The use of PORT in oral cavity cancer involves substantial acute toxicity, and even more concerning, a significant risk for late effects [8,9] that might impair the patients' quality of life [10,11] yet is not based upon randomized evidence [4]. Some studies have failed to demonstrate a benefit for PORT in head and neck squamous cell carcinoma (HNSCC) [12,13].…”
mentioning
confidence: 99%
“…In particular, emerging data suggest that baseline (pretreatment) quality of life (QOL) assessment or simple objective physical function tests may predict outcomes such as mortality and toxicity in oncology (11)(12)(13) , although there are very limited data in AML patients (10,(14)(15) . A recent study by Klepin et al found that overall survival was significantly shorter for older AML patients with impairment in self-reported cognitive function (a QOL domain) and objectively measured physical function after adjusting for age, performance status and cytogenetic risk group (16) .…”
Section: Introductionmentioning
confidence: 99%